PL Jager
Impact in
- Biochemistry top 5%
- Amino Acid Enzymes and Metabolism
- Genetics top 10%
- Glioma Diagnosis and Treatment
Papers in
-
- Medical Imaging and Pathology Studies 4
- Vasculitis and related conditions 3
- Lung Cancer Diagnosis and Treatment 2
-
- Medical Imaging Techniques and Applications 9
- Radiopharmaceutical Chemistry and Applications 5
- Cardiac Imaging and Diagnostics 3
- Co-authors
- DA Piers (11 shared papers)Elisabeth G.E. de Vries (7 shared papers)Willem Vaalburg (4 shared papers)Jan Pruim (2 shared papers)Karl‐Josef Langen (1 shared paper)Marc Bijl (2 shared papers)W.J. Sluiter (2 shared papers)Harry J.M. Groen (2 shared papers)
- Journals
- European Journal of Nuclear Medicine and Molecular Imaging (2 papers)European Journal of Endocrinology (1 paper)European Heart Journal - Cardiovascular Imaging (1 paper)European Journal of Gastroenterology & Hepatology (1 paper)British Journal of Pharmacology (1 paper)
- Partner nations
- NetherlandsUnited StatesPakistan
In The Last Decade
PL Jager
22 papers receiving 612 citations
Peers
Comparison fields: 5 of 60
- Biochemistry 164
- Genetics 156
- Radiology, Nuclear Medicine and Imaging 323
- Clinical Biochemistry 48
- Cancer Research 82
Countries citing papers authored by PL Jager
This map shows the geographic impact of PL Jager's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by PL Jager with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites PL Jager more than expected).
Fields of papers citing papers by PL Jager
This network shows the impact of papers produced by PL Jager. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by PL Jager. The network helps show where PL Jager may publish in the future.
Co-authors
The 25 scholars most cited alongside PL Jager, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Radiolabeled amino acids: basic aspects and clinical applications in oncology. | 2001 | 450 |
| 2 | 2003 | 62 | |
| 3 | Additional value of positron emission tomography in diagnosis and follow-up of patients with large vessel vasculitides. | 2004 | 49 |
| 4 | 2011 | 14 | |
| 5 | L-3-[123I]iodo-alpha-methyl-tyrosine SPECT in non-small cell lung cancer: preliminary observations. | 2001 | 14 |
| 6 | L-3-[123I]Iodo-alpha-methyltyrosine scintigraphy in carcinoid tumors: correlation with biochemical activity and comparison with [111In-DTPA-D-Phe1]-octreotide imaging. | 2000 | 12 |
| 7 | 2003 | 7 | |
| 8 | Characterisation of the uptake mechanism of L-3-[I-126]-Iodo-alpha-methyl-tyrosine in Glc4 tumor cells : Comparison with L-1-[C-14]-tyrosine | 1999 | 4 |
| 9 | Clinical value of kinetic studies with I-123 labeled serum amyloid p component (SAP) in patients with systemic amyloidosis. | 1997 | 4 |
| 10 | Bone scintigraphy in oncology | 2004 | 3 |
| 11 | A feasibility study of sentinel lymph node scintigraphy in staging of esophageal cancer. | 2004 | 1 |
| 12 | The clinical value of gallium-67 scintigraphy in Wegener's granulomatosis | 2001 | 1 |
| 13 | Similar cardiac event free survival in PET and SPECT based patient management | 2000 | 1 |
| 14 | 2005 | 1 | |
| 15 | Lymphoscintigraphy to identify unusual locations of sentinel lymph nodes in patients with breast cancer | 1999 | 1 |
| 16 | 2021 | 1 | |
| 17 | PET studies of human airways using inhaled C-11 CGP 12388. | 2002 | 1 |
| 18 | Detection and differentiation of low and high grade sarcoma with FLT PET. | 2003 | 1 |
| 19 | Evaluation of 123-Iodo-alpha-methyl-tyrosine SPECT in primary lung cancer. | 1999 | 1 |
| 20 | Correspondence re: H. Barthel et al., 3 '-deoxy-3 '-[F-18]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography. Cancer Res., 63: 3791-3798,2003. | 2003 | 1 |
About PL Jager
PL Jager is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Surgery, Molecular Biology and Epidemiology, having authored 23 papers that have together received 631 indexed citations. Recurring topics across this work include Medical Imaging Techniques and Applications (9 papers), Radiopharmaceutical Chemistry and Applications (5 papers), Medical Imaging and Pathology Studies (4 papers), Vasculitis and related conditions (3 papers), Cardiac Imaging and Diagnostics (3 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (2 papers), Lung Cancer Diagnosis and Treatment (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). The work is most often cited by research in Biochemistry (164 citations), Genetics (156 citations), Radiology, Nuclear Medicine and Imaging (323 citations), Clinical Biochemistry (48 citations) and Cancer Research (82 citations). PL Jager has collaborated with scholars based in Netherlands, United States and Pakistan. Frequent co-authors include DA Piers, Elisabeth G.E. de Vries, Willem Vaalburg, Jan Pruim, Karl‐Josef Langen, Marc Bijl, W.J. Sluiter, Harry J.M. Groen, Evelien W. Duiker and Hiddo J.L. Heerspink. Their work appears in journals such as European Journal of Nuclear Medicine and Molecular Imaging, European Journal of Endocrinology, European Heart Journal - Cardiovascular Imaging, European Journal of Gastroenterology & Hepatology and British Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.